Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC

Detalles Bibliográficos
Autores principales: Daniel, Catherine, Callens, Celine, Melaabi, Samia, Bieche, Ivan, Girard, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474206/
https://www.ncbi.nlm.nih.gov/pubmed/34589961
http://dx.doi.org/10.1016/j.jtocrr.2020.100082
_version_ 1784575161748422656
author Daniel, Catherine
Callens, Celine
Melaabi, Samia
Bieche, Ivan
Girard, Nicolas
author_facet Daniel, Catherine
Callens, Celine
Melaabi, Samia
Bieche, Ivan
Girard, Nicolas
author_sort Daniel, Catherine
collection PubMed
description
format Online
Article
Text
id pubmed-8474206
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84742062021-09-28 Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC Daniel, Catherine Callens, Celine Melaabi, Samia Bieche, Ivan Girard, Nicolas JTO Clin Res Rep Case Report Elsevier 2020-08-07 /pmc/articles/PMC8474206/ /pubmed/34589961 http://dx.doi.org/10.1016/j.jtocrr.2020.100082 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Daniel, Catherine
Callens, Celine
Melaabi, Samia
Bieche, Ivan
Girard, Nicolas
Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
title Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
title_full Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
title_fullStr Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
title_full_unstemmed Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
title_short Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
title_sort acquired exon 14 met mutation associated with resistance to alectinib in a patient with alk–rearranged nsclc
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474206/
https://www.ncbi.nlm.nih.gov/pubmed/34589961
http://dx.doi.org/10.1016/j.jtocrr.2020.100082
work_keys_str_mv AT danielcatherine acquiredexon14metmutationassociatedwithresistancetoalectinibinapatientwithalkrearrangednsclc
AT callensceline acquiredexon14metmutationassociatedwithresistancetoalectinibinapatientwithalkrearrangednsclc
AT melaabisamia acquiredexon14metmutationassociatedwithresistancetoalectinibinapatientwithalkrearrangednsclc
AT biecheivan acquiredexon14metmutationassociatedwithresistancetoalectinibinapatientwithalkrearrangednsclc
AT girardnicolas acquiredexon14metmutationassociatedwithresistancetoalectinibinapatientwithalkrearrangednsclc

Ejemplares similares